Capivasertib and fulvestrant for AI-resistant HR+/HER2- ABC
Hope Rugo
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Renowned experts in oncology share their knowledge in our Breaking Science, Insight and Education Videos
The selection of study results covered in this track is exclusively under the responsibility of ESMO and the speakers selected by ESMO.
Latest practice changing studies in Breast Cancer from ESMO Breast Cancer 2024
Series objectives: To provide oncologists all over the world with succinct summaries of the most important study results on Breast Cancer, delivered by leading experts in video interviews.
Hope Rugo
Peter Schmid
Mafalda Oliveira
Matteo Lambertini
Séverine Guiu
Guillermo Villacampa
Komal Jhaveri
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.